products NEXT-SCN World-first multimodal platform that measures in-vivo synaptic integrity to objectively verify the impact of synapse-targeted therapies.
products NEXT-STAGE MRI in, tau insight out. NEXT‑STAGE infers regional tau burden from routine MRI noninvasive, scalable, and cost‑effective. PET‑complementary, built for research teams in biopharma and academic hospitals.